EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Severe dengue: Are type I interferon autoantibodies involved?

Vu Le-Huy Tran iD, Alessandro Borghesi iD, Jean-Laurent Casanova iD, Shen-Ying Zhang iD

Journal of Human Immunity · 04.01.2027 · 3 (1)

DOI: 10.70962/jhi.20260214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Human Immunity, online erschienen am 12.11.2026. Verfasst von Vu Le-Huy Tran und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Genetics of Infectious Diseases, University of Texas Southwestern, Dallas, TX, USA. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HORIZON-HLTH-2021-DISEASE-04, NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dengue virus (DENV) is the most rapidly disseminating arbovirus worldwide. A new study by Yang et al. (https://doi.org/10.70962/jhi.20260072) shows that autoantibodies neutralizing type I IFNs (AAN-I-IFN) may underlie severe dengue in ∼14% (7/49) of cases in a cohort of Chinese patients. Further studies of children and adults of different ancestries with silent, benign, and severe DENV infection are warranted.

Autor:innen und Institutionen

  • Laboratory of Human Genetics of Infectious Diseases, University of Texas Southwestern, Dallas, TX, USA.
  • Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center , Dallas, TX, USA.
  • Neonatal and Pediatric Intensive Care Unit, Mother, Child and Adolescent Department, Geneva University Hospitals, Geneva, Switzerland.
  • Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Geneva, Switzerland.
  • Host-Pathogen Interaction Unit, San Matteo Research Hospital (Fondazione IRCCS Policlinico San Matteo), Pavia, Italy.
  • Global Health Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne , Lausanne, Switzerland.

ORCID-Profile: Vu Le-Huy Tran, Alessandro Borghesi, Jean-Laurent Casanova, Shen-Ying Zhang

Förderung

  • NIAID NIH HHS
  • HORIZON-HLTH-2021-DISEASE-04
  • NIH HHS
  • Paris Cité University
  • Square Foundation
  • French Agence Nationale de la Recherche
  • Howard Hughes Medical Institute
  • SCOR Corporate Foundation for Science

Zitieren

APA

Tran, V. L., Borghesi, A., Casanova, J. L., & Zhang, S. Y. (2027). Severe dengue: Are type I interferon autoantibodies involved?. Journal of Human Immunity, 3(1). https://doi.org/10.70962/jhi.20260214

Vancouver

Tran VL, Borghesi A, Casanova JL, Zhang SY. Severe dengue: Are type I interferon autoantibodies involved?. Journal of Human Immunity. 2027;3(1). doi:10.70962/jhi.20260214

BibTeX
@article{Tran2027,
  author = {Tran, Vu Le-Huy and Borghesi, Alessandro and Casanova, Jean-Laurent and Zhang, Shen-Ying},
  title = {Severe dengue: Are type I interferon autoantibodies involved?},
  journal = {Journal of Human Immunity},
  year = {2027},
  volume = {3},
  number = {1},
  doi = {10.70962/jhi.20260214}
}
Kostenlos starten →